SIRPA and neoplasm: The changed number/phenotype of macrophages and expression level of SIRPα indicate that the bacterial lysates in tumors in G4 may have enhanced the therapeutic efficacy of CD47nb, since the main anticancer mechanism of CD47nb relies on the CD47-SIRPα signaling pathway to induce phagocytosis of tumor cells34.